589
Participants
Start Date
May 31, 2010
Primary Completion Date
June 30, 2011
Study Completion Date
June 30, 2011
Agomelatine (AGO178C)
Placebo
Eastside Comprehensive Medical Service, New York
Social Psychiatric Research Institute, Brooklyn
CRI Worldwide, LLC - Kirkbride Division, Philadelphia
Pharmasite Research, Pikesville
Medical University of South Carolina, North Charleston
Emory University, Atlanta
ICSL Clinical Studies, Altamonte Springs
Arocha Research Center, Coral Gables
Miami Research Associates, South Miami
Innova Clinical Trials, Miami
Florida Clinical Research Center, LLC, Bradenton
University of Alabama at Birmingham, Department of Psychiatry, Birmingham
CNS Healthcare, Memphis
Research Strategies, Memphis
Neurology & Neuroscience Center of Ohio, Toledo
Neurobehavioral Clinical Research, Canton
University of Cincinnati Medical Center, Cincinnati
Deaconess Clinic, Evansville
CNS Clinical Trials, Park Ridge
Alexian Brothers Center for Psychiatric Research, Hoffman Estates
Joliet Center for Clinical Research, Joliet
Mercy Health Research, St Louis
Heartland Research Associates, LLC, Wichita
Premier Psychiatry Group, LLC, Lincoln
SP Research, Oklahoma City
Claghorn-Lesem Research Clinic, Inc., Houston
FutureSearch Trials, Austin
University of Utah, Department of Psychiatry, Salt Lake City
California Neuroscience Research Medical Group, Inc., Sherman Oaks
Affiliated Research Institute, San Diego
Valley Clinical Research, El Centro
Anderson Clinical Research, Redlands
Viking Clinical Research, Temecula
ATP Clinical Research, Costa Mesa
Collaborative Neuroscience Network, Garden Grove
University of California, Irvine Medical Center, Orange
Summit Research Network, Portland
Willamette Valley Clinical Studies, Eugene
Northwest Clinical Research Center, Bellevue
Summit Research, Seattle
Massachusetts General Hospital, Boston
Boston Clinical Trials, Brighton
CRI Worldwide, LLC - Lourdes Division, Willingboro
Caribbean Research and Education Center, Bayamón
Dharma Institute and Research Center, San Juan
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY